EN DE
Watch Cosmax for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Cosmax (044820) fair value: what the stock is really worth

As of Nov 18, 2026: fair value (intrinsic value) of Cosmax stock KRW 25,298, price KRW 23,250, upside +8.8%, quality 50 out of 100. Rating: fairly valued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive KR · ISIN KR7044820009

C Cosmax logo Broad data Nov 14, 2026

Cosmax

044820 · KO

Solid company and rising price, but the stock is already about fairly priced: meets 2 of 3 rules.

Follow free in the weekly email
Rising price (uptrend) 
Low debt 
Generates free cash flow 
Ranks above peers (12/14) 
Broad data 
Costs just 3.5 times its yearly profit. 
Fair value 25,298 KRW · Fairly valued 
Quality 50/100 
Mixed Growth (revenue 5y +4.2 %/yr in KRW) 
Thin margins · 8.3% net margin (TTM) 
3.4% dividend yield · Watch coverage
Moderate moat 49/100 · thin data
Changed on Nov 9: KRW 43,598 → KRW 25,298 
Watch Cosmax for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

28,000 KRW 6,096 KRW Fair Value 25,298 KRW Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range 6,096 KRW – 28,000 KRW · fair‑value band 25,298 KRW – 36,692 KRW · the 23,250 KRW price screens below the 25,298 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow Cosmax in your weekly email

Every Wednesday you see whether Cosmax is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea.

Show moreShow less

The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmetics; and cosmeceuticals.

It also provides health supplement products in form of gels, capsules, and powders; and medical devices. In addition, the company exports its products. Cosmax BTI, Inc. was founded in 1984 and is headquartered in Seongnam-si, South Korea.

Stock analysis

Cosmax (044820) currently trades at 23,250 KRW, while our model-based Fair Value estimate is 25,298 KRW, so the stock looks roughly fairly valued today (gap 8.1%).

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 54,398 KRW per share, and 16 of the 24 models we run sit above the 23,250 KRW price.

Bear case: the Dividend Discount group reads lowest at 3,975 KRW, and 8 of the 24 models stay below the price. Data coverage for this calculation is high.

Scenario range: 25,298 KRW (bear) to 36,692 KRW (bull), the price of 23,250 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 50/100 (solid quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Cosmax reported revenue of 645B KRW in FY2025 versus 576B KRW in FY2021, a compound +2.9%/yr. Reported net income was 29.2B KRW in FY2025, compounding +19.9%/yr from FY2021.

Key figures

Market cap 222B KRW (≈ $167M) Micro · P/E ratio 3.5 · P/S ratio 0.39 · EPS (TTM) 6,675 KRW · Dividend yield 3.4% · Net margin 8.3% · Return on equity 24.7% · Return on assets (EBIT) 1.7% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 49 out of 100 (low confidence).

What moves the price

The share trades about 17% below its 52-week high and 103% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −8% fair-value upside, at 9%, 044820 screens cheaper than that median.

Fair Value models

Bear 25,298 KRW Fair Value 25,298 KRW Bull 36,692 KRW
Price 23,250 KRW · Upside +8.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then (5,201 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 18,186 KRW 24,763 KRW 34,092 KRW 80
Growth DCF 18,037 KRW 23,849 KRW 31,583 KRW 78
Residual Income 23,597 KRW 25,298 KRW 29,504 KRW 76
All 25 models by family
DCF Models
FCF DCF 18,186 KRW 24,763 KRW 34,092 KRW 80
Owner Earnings 38,716 KRW 56,831 KRW 82,526 KRW 75
5Y Revenue Exit 22,080 KRW 33,875 KRW 49,734 KRW 71
5Y EBITDA Exit 33,223 KRW 56,275 KRW 84,994 KRW 73
5Y P/E Exit 37,121 KRW 64,112 KRW 94,638 KRW 69
10Y Revenue Exit 19,763 KRW 29,431 KRW 43,871 KRW 65
10Y EBITDA Exit 26,656 KRW 43,598 KRW 69,080 KRW 66
10Y P/E Exit 28,899 KRW 48,554 KRW 75,975 KRW 62
Earnings-Based
Graham-Dodd 20,787 KRW 88,653 KRW 121,081 KRW 64
Lynch FV 24,649 KRW 35,213 KRW 45,777 KRW 61
PEG = 1.0 24,649 KRW 35,213 KRW 45,777 KRW 57
EPV 14,899 KRW 15,954 KRW 16,818 KRW 73
Dividend Discount
Gordon GGM 2,392 KRW 4,104 KRW 5,426 KRW 68
DDM Multi-Stage 2,392 KRW 3,846 KRW 4,406 KRW 67
Multiples
P/E Multiple 48,146 KRW 64,195 KRW 80,244 KRW 63
P/S Multiple 38,976 KRW 51,968 KRW 64,960 KRW 57
P/B Multiple 9,819 KRW 13,092 KRW 16,365 KRW 55
EV/EBIT n/a 3,785 KRW 12,606 KRW 60
EV/EBITDA 9,417 KRW 23,054 KRW 36,692 KRW 62
EV/Revenue n/a n/a 3,578 KRW 49
Asset-Based
NCAV (Graham) 13,055 KRW 17,494 KRW 26,110 KRW 53
Growth DCF
Growth DCF 18,037 KRW 23,849 KRW 31,583 KRW 78
Economic Profit
Residual Income 23,597 KRW 25,298 KRW 29,504 KRW 76
ROIC Compounder 14,899 KRW 15,954 KRW 16,818 KRW 71
Growth Earnings
Growth-Adj P/E 38,079 KRW 54,398 KRW 70,717 KRW 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 50/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 35
How much profit the company makes from its sales and capital
Quality Growth 57
Are margins and returns getting better?
Cashflow 24
Do the profits arrive as real cash?
Financial strength 16
Debt, balance sheet and risk of trouble
Investment 90
Does it invest with discipline instead of growing at any price?
Low Volatility 48
How calm the share price moves, does not count
Price momentum 60
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 86
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+8.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.2%
Start year 2020 (pandemic). Over 10 years: +12.4% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.0%
What shareholders gained per year (last 5 years), in KRW (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+49.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+45.9%
Dividend (yield on the price)3.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.32.1% vs 6.6%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 4%
2025 sits 129% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+69.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +66.4% a year for the price.

Watch 044820, get fair value alerts →

Compare Cosmax with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 663 stocks

Beats the industry median on 12/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 50 · Below median
Fair Value upside +8.8% · Above median
Profitability
Return on equity (12 months) 24.7% · Top 25%
Return on assets 4.0% · Above median
Net margin (12 months) 11.3% · Top 25%
Operating margin (12 months) 6.8% · Above median
Growth and dividend
Revenue growth (quarter YoY) 46.0% · Top 25%
Dividend yield (12 months) 3.4% · Above median
Balance sheet
Debt / equity 0.06× · Below median

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/E (12 months) 3.5× · Cheapest 25%
P/B 0.81× · Cheaper than median
P/S (12 months) 0.39× · Cheaper than median
Price / free cash flow (fiscal year) 121.3× · Priciest 25%
EV/EBITDA 2.7× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)45 · sector 35
FUTURE (revenue growth)100 · sector 26
PAST (return on equity)99 · sector 31
HEALTH (low debt)97 · sector 96
DIVIDEND (yield)67 · sector 54

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.92 SGD 4.95 SGD +70% vs 044820
Inner Mongolia Yili Industrial Group 600887 ¥32.39 ¥41.84 +29% vs 044820
The Kraft Heinz Company KHC $25.11 $29.20 +16% vs 044820
Foshan Haitian Flavouring and Food Company 603288 ¥35.99 ¥39.82 +11% vs 044820
General Mills, Inc GIS $34.68 $31.99 −8% vs 044820
Danone S.A BN €69.16 €50.65 −27% vs 044820
Nestlé S.A NESN CHF 86.03 CHF 59.51 −31% vs 044820
Kerry Group KRZ €102.30 €60.76 −41% vs 044820
Nestlé India Limited NESTLEIND ₹1,282 ₹724.74 −43% vs 044820
Yihai Kerry Arawana Holdings 300999 ¥25.28 ¥12.21 −52% vs 044820

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cosmax: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Cosmax Fair Value". https://www.fairvalue-calculator.com/stock/044820

Frequently asked questions

Is Cosmax (044820) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of 25,298 KRW versus a price of 23,250 KRW, about +9% upside (fairly valued).
What is the fair value of 044820?
Our model-based fair value for Cosmax is 25,298 KRW (as of Nov 14, 2026), built from audited fundamentals. The current price: 23,250 KRW.
What is the quality score of 044820?
Cosmax has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cosmax (044820)?
Our model-based price target is the fair value of 25,298 KRW (as of Nov 14, 2026) from 25 valuation models. Cautious scenario 25,298 KRW, optimistic scenario 36,692 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cosmax stock forecast for 2026?
Our models put fair value at 25,298 KRW, about +9% upside versus a price of 23,250 KRW (fairly valued). Cautious scenario 25,298 KRW, optimistic scenario 36,692 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cosmax (044820)?
Cosmax reported trailing-twelve-month revenue of about 771B KRW (latest available figure, as of Nov 14, 2026).
Does Cosmax pay a dividend?
Cosmax currently shows a dividend yield of 3.35% relative to its recent price (as of Nov 14, 2026).
How much is the dividend of Cosmax (044820) and when is the ex-dividend date?
Cosmax pays a dividend of 780.00 KRW per share a year, a dividend yield of 3.4%. The last ex-dividend date was Mar 30, 2026. The payout ratio is 11.7% of earnings. Free cash flow covers the dividend 0.33 times. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What growth is priced into Cosmax (044820)?
For today's price to be fair in a discounted-cash-flow model, Cosmax would have to grow free cash flow by 69.8 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 4.2 % per year. As of Nov 14, 2026.
What discount rate (WACC) does the fair value of 044820 use?
Our models discount Cosmax at 12.0 %: a base by market capitalisation (micro), damped by beta 0.64, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cosmax that is +69.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.0 %) and the same formula as our fair value.
How much growth has Cosmax (044820) delivered so far?
Over the past 5 years revenue at Cosmax grew 4.2 % a year. The price currently implies free-cash-flow growth of +69.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cosmax (044820) growing?
The median revenue growth in the sector is +3.9 % a year. That is the yardstick for the growth priced into Cosmax (+69.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cosmax (044820)?
The free-cash-flow yield on the price is 1.12 %: that much free cash flow Cosmax produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cosmax (044820)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cosmax it is 25,298 KRW per share (as of Nov 14, 2026), against a price of 23,250 KRW. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Cosmax stock overvalued or undervalued in 2026?
As of Nov 14, 2026, 044820 trades below its calculated fair value: price 23,250 KRW, fair value 25,298 KRW, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 044820?
No. The price is what the market pays today (23,250 KRW); the fair value is what the company's own numbers justify (25,298 KRW). For Cosmax the two are 2,048 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cosmax worth?
The market values Cosmax at about 222B KRW (market capitalisation, as of Nov 14, 2026). Per share that is 23,250 KRW; our models calculate a fair value of 25,298 KRW per share.
What do the bullish and bearish scenarios say about 044820?
Our models span a range for Cosmax: cautious scenario 25,298 KRW, base 25,298 KRW, optimistic 36,692 KRW per share (as of Nov 14, 2026, price 23,250 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 044820?
Cosmax trades at a price-to-earnings ratio of 3.5 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 25,298 KRW is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2016 to 2025), reported earnings: 15.4. Other multiples: P/B 0.8, P/S 0.4, EV/EBITDA 2.7.
How solid is the balance sheet of Cosmax (044820)?
Balance-sheet figures for Cosmax (as of Nov 14, 2026): return on equity 24.7%, debt of 0.06 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is 044820 from its 52-week high?
Cosmax trades at 23,250 KRW, about 17% below its 52-week high of 28,000 KRW and 103% above the low of 11,450 KRW (as of Nov 18, 2026). Distance from the high says nothing about value: that is what the fair value of 25,298 KRW is for.
Which stocks are comparable to Cosmax?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, Inner Mongolia Yili Industrial Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cosmax stock attractive at the current price?
The data as of Nov 14, 2026: price 23,250 KRW, calculated fair value 25,298 KRW (+9%), Quality Score 50/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 044820 calculated?
We run Cosmax through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 25,298 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3% above its aggregate fair value. Cosmax currently trades 8% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cosmax (044820)?
The closing price on Nov 18, 2026 was 23,250 KRW. Our model-based fair value is 25,298 KRW, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cosmax right now?
The price is below even our cautious bear case (25,298 KRW). The market is more pessimistic than our downside scenario. The price sits close to our fair value, market and models broadly agree here, little valuation tension.

Key figures of Cosmax

How large is the market capitalisation of Cosmax (044820)?
The market capitalisation of Cosmax is 222B KRW (≈ $167M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cosmax (044820)?
The price-to-sales ratio of Cosmax is 0.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cosmax (044820)?
Earnings per share at Cosmax are 6,675 KRW (price ÷ EPS = P/E 3.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cosmax (044820)?
The dividend yield of Cosmax is 3.4% (payout 11.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cosmax (044820)?
The net margin of Cosmax is 8.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cosmax (044820)?
The return on equity (ROE) of Cosmax is 24.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cosmax (044820)?
On an EBIT basis the return on assets of Cosmax is 1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cosmax (044820)?
The operating margin of Cosmax is 6.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cosmax (044820)?
Revenue at Cosmax is growing 46.0% versus a year earlier (3y avg +1.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cosmax (044820)?
Earnings per share at Cosmax are growing 259% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Cosmax (044820) carry?
The net debt of Cosmax is 410B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Cosmax in the live analysis

One click puts Cosmax on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.